1.Clinical significance of soft markers in second trimester ultrasonography for pregnant Korean women: a multicenter study and literature review
Hyun Sun KO ; Dong Wook KWAK ; Soo-young OH ; Sae Kyung CHOI ; Joon Seok HONG ; Han Sung HWANG ; Hyun Soo PARK ; Hyun-Joo SEOL ; Moon Young KIM ; Sa Jin KIM ; Joong Shin PARK
Obstetrics & Gynecology Science 2022;65(2):145-155
Objective:
To evaluate the clinical significance of soft markers for aneuploidy screening in Korean women.
Methods:
We retrospectively reviewed the medical records of 5,428 singleton pregnant women who underwent sonography during the second trimester at seven institutions in South Korea. We evaluated the prevalence of the following soft markers: intracardiac echogenic focus, choroid plexus cysts, pyelectasis, echogenic bowel, and mild ventriculomegaly. We developed best-fitted regression equations for the fetal femur and humerus length using our data and defined a short femur and humerus as both long bones below the fifth centile. The results of genetic testing and postnatal outcomes were investigated in patients who had been diagnosed with aforementioned soft markers.
Results:
The median maternal age of our study population was 33 years, and the median gestational age at the time of ultrasonographic examination was 21 weeks. We detected soft markers in 10.0% (n=540) of fetuses: 9.3% (n=504) were isolated cases and 0.7% (n=36) of cases had two or more markers. We identified only two aneuploides (trisomy 18, 46,XX,t[8;10][q22.1;p13]), of which one was clinically significant. We presented the neonatal outcomes of the fetuses with the respective soft markers. Preterm delivery, low birth weight, and small-for-gestational-age (SGA) were significantly more common in women with a shortened fetal femur (P<0.001, all). However, the presence of a shortened fetal humerus was not associated with those outcomes excluding SGA.
Conclusion
Soft markers in second-trimester ultrasonography have limited use in screening for fetal aneuploidy in Korean women. However, these markers can be used as a screening tool for adverse outcomes other than chromosomal abnormality.
2.A Comparison of Predictive Performances between Old versus New Criteria in a Risk-Based Screening Strategy for Gestational Diabetes Mellitus
Subeen HONG ; Seung Mi LEE ; Soo Heon KWAK ; Byoung Jae KIM ; Ja Nam KOO ; Ig Hwan OH ; Sohee OH ; Sun Min KIM ; Sue SHIN ; Won KIM ; Sae Kyung JOO ; Errol R. NORWITZ ; Souphaphone LOUANGSENLATH ; Chan-Wook PARK ; Jong Kwan JUN ; Joong Shin PARK
Diabetes & Metabolism Journal 2020;44(5):726-736
The definition of the high-risk group for gestational diabetes mellitus (GDM) defined by the American College of Obstetricians and Gynecologists was changed from the criteria composed of five historic/demographic factors (old criteria) to the criteria consisting of 11 factors (new criteria) in 2017. To compare the predictive performances between these two sets of criteria. This is a secondary analysis of a large prospective cohort study of non-diabetic Korean women with singleton pregnancies designed to examine the risk of GDM in women with nonalcoholic fatty liver disease. Maternal fasting blood was taken at 10 to 14 weeks of gestation and measured for glucose and lipid parameters. GDM was diagnosed by the two-step approach. Among 820 women, 42 (5.1%) were diagnosed with GDM. Using the old criteria, 29.8% ( Compared with the old criteria, use of the new criteria would have decreased the number of patients identified as high risk and thus requiring early GDM screening by half (from 244 [29.8%] to 131 [16.0%]).
3.A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-Line Chemotherapy in Metastatic Colorectal Cancer Patients
Youjin KIM ; Tae Won KIM ; Sae Won HAN ; Joong Bae AHN ; Seung Tae KIM ; Jeeyun LEE ; Joon Oh PARK ; Young Suk PARK ; Ho Yeong LIM ; Won Ki KANG
Cancer Research and Treatment 2019;51(3):1128-1134
PURPOSE: Simvastatin has demonstrated anti-tumor activity in preclinical studies via tumor cell senescence, apoptosis, and anti-angiogenesis. This phase II trial evaluated the efficacy and toxicity profile of conventional XELOX and bevacizumab chemotherapy plus simvastatin in metastatic colorectal cancer patients (MCRC). MATERIALS AND METHODS: Patients with MCRC received first-line XELOX in 3-week treatment cycles of intravenous oxaliplatin 130 mg/m² plus bevacizumab 7.5 mg/kg (day 1), followed by oral capecitabine 1,000 mg/m² twice daily (day 1-14). Simvastatin 80 mg tablets were taken orally once daily every day during the period of chemotherapy. The primary endpoint was progression-free survival (PFS). Secondary endpoints were response rate, duration of response, overall survival (OS), time to progression, and toxicity. RESULTS: From January 2014 to April 2015, 60 patients were enrolled and 55 patients were evaluable for tumor response. The median follow-up duration was 30.1 months (range, 28.5 to 31.7 months). The median PFS was 10.4 months (95% confidence interval [CI], 9.6 to 11.1). The median OS of all patients was 19.0 months (95% CI, 11.9 to 26.0). The disease-control rate and overall response rate were 88.3% (95% CI, 74 to 96) and 58.3% (95% CI, 44 to 77), respectively, by intent-to-treat protocol analysis. There was one complete response and 34 partial responses. One patient experienced grade 3 creatine kinase elevation and liver enzyme elevation. CONCLUSION: Based on the current study, the addition of 80 mg simvastatin to XELOX and bevacizumab showed comparable clinical efficacy in patients with MCRC as first-line chemotherapy and did not increase toxicity.
Apoptosis
;
Arm
;
Bevacizumab
;
Capecitabine
;
Cell Aging
;
Colorectal Neoplasms
;
Creatine Kinase
;
Disease-Free Survival
;
Drug Therapy
;
Follow-Up Studies
;
Humans
;
Liver
;
Simvastatin
;
Tablets
;
Treatment Outcome
4.A Successful Case of a High Anti A/B Antibody Titer ABO Incompatible Kidney Transplantation Patient Who Received a Kidney from a Hepatitis B Carrier.
Jin Ho LEE ; Han Sae KIM ; Dong Yeol LEE ; Joon Seok OH ; Yong Hun SIN ; Joong Kyung KIM ; Jong Hyun PARK ; Kill HUH ; Jong In PARK
The Journal of the Korean Society for Transplantation 2016;30(4):184-189
Kidney transplantation (KTP) lowers the mortality and morbidity of patients with end-stage renal disease. Post-transplantation infection and antibody mediated rejection (AMR) are the most common complications. Hepatitis B surface antigen (HBsAg) positive carrier donors and high anti A/B antibody titer ABO incompatible KTP could lead to recipient hepatitis B virus (HBV) infection and AMR. Here, we report a case of successful KTP in a 41-year-old male with a high titer of ABO incompatible and HBsAg positive donor. He underwent seven rounds of plasmapheresis, low dose intravenous immunoglobulin and rituximab treatment to inhibit antibody production and remove antibodies from the serum, after which he was administered anti-viral agent for HBV prophylaxis. The recipient maintained successful allograft function for 6 months after transplantation; therefore, we report that desensitization and anti-viral treatment achieved successful outcome in a 1:512 anti A/B antibody titer ABO incompatible and hepatitis B carrier donor KTP.
Adult
;
Allografts
;
Antibodies
;
Antibody Formation
;
Hepatitis B Surface Antigens
;
Hepatitis B virus
;
Hepatitis B*
;
Hepatitis*
;
Humans
;
Immunoglobulins
;
Kidney Failure, Chronic
;
Kidney Transplantation*
;
Kidney*
;
Male
;
Mortality
;
Plasmapheresis
;
Rituximab
;
Tissue Donors
5.Successful Balloon Angioplasty with Low-pressure Balloon on Early Transplant Renal Artery Stenosis at Postoperative Day 7.
Doo Youp KIM ; Hyun Do JUNG ; Jin Ho LEE ; Han Sae KIM ; Dong Yeol LEE ; Joon Seok OH ; Seong Min KIM ; Yong Hun SIN ; Joong Kyung KIM ; Kill HUH ; Jong Hyun PARK ; Gyu Sik JUNG
The Journal of the Korean Society for Transplantation 2016;30(2):103-107
Transplant renal artery stenosis (TRAS) is an important cause of hypertension, allograft dysfunction, and graft loss. Patient and allograft survival rates are lower in patients with TRAS. Causes of TRAS include acute rejection, cytomegalovirus infection, calcineurin inhibitor toxicity, atherosclerosis of recipient, and/or donor. Technical problems due to surgery are a common cause of early TRAS. A 62-year-old male in end stage renal disease received kidney transplant surgery. There was 5/6 mismatch of human leukocyte antigen and the panel reactive antibody of patient was class I 0% and class II 0%. End to side anastomosis was done between the graft's renal artery and the patient's common iliac artery. His serum creatinine was measured at 6.4 mg/dL before transplantation but his serum creatinine level did not fall below 2.6 mg/dL at 5 days postoperative. His blood pressures was 160/90~180/100 mmHg. There was a significant TRAS (about 80% luminal narrowing) at the arterial anastomosis site on the renal magnetic resonance angiography. We performed percutaneous transluminal angioplasty (PTA) for the stenotic lesion. The balloon angioplasty was done with a 5 mm balloon and low pressure (8 mmHg, nominal pressure was 10 mmHg) at the stenotic lesion. The arterial pressure gradient was 8 mmHg (recipient's common iliac arterial pressure, 147/73 mmHg; poststenotic segmental renal arterial pressure, 139/70 mmHg) just before the balloon angioplasty. After PTA, the arterial pressure gradient became 3 mmHg (recipient's common iliac arterial pressure, 157/66 mmHg; poststenotic segmental renal arterial pressure, 154/65 mmHg). The arterial size and blood flow recovered to within normal range and serum creatinine level was normal after PTA. PTA using low pressure and a small balloon was safe and effective modality in treating early TRAS.
Allografts
;
Angioplasty
;
Angioplasty, Balloon*
;
Arterial Pressure
;
Atherosclerosis
;
Calcineurin
;
Creatinine
;
Cytomegalovirus Infections
;
Humans
;
Hypertension
;
Iliac Artery
;
Kidney
;
Kidney Failure, Chronic
;
Kidney Transplantation
;
Leukocytes
;
Magnetic Resonance Angiography
;
Male
;
Middle Aged
;
Phenobarbital
;
Reference Values
;
Renal Artery Obstruction*
;
Renal Artery*
;
Survival Rate
;
Tissue Donors
;
Transplants
6.Dietary Analysis of Kidney Transplant Patients Who Eat Korean Foods: Single Center Study.
Han Sae KIM ; Joon Seok OH ; Dong Yeol LEE ; Jin Ho LEE ; Seung Min KIM ; Yong Hun SHIN ; Yong Soon PARK ; Won Suk AN ; Joong Kyung KIM
The Journal of the Korean Society for Transplantation 2015;29(2):68-74
BACKGROUND: Although nutritional problems associated with dialysis are well described, nutritional problems after renal transplantation have received little attention. Nutrition interventions play an important role in prevention and management of common health problems associated with renal transplantation such as obesity, hypertension, diabetes, and cardiovascular disease. METHODS: Sixty-four kidney transplant recipients who received post-transplant management at our hospital replied to the questionnaire. The questionnaire included 102 questions on the amount and types of Korean foods that they consumed last week. Nutritional elements of diet in renal transplant patients who consume Korean food were analyzed on the basis of the survey. RESULTS: The mean energy and protein of daily intake were 2,088+/-1,016 kcal and 75.5+/-38.2 g. Patients' diets were generally sufficient, but characterized by deficiencies in vitamin B2, vitamin D, niacin, calcium, and magnesium intake. CONCLUSIONS: Dietary advice is required with regard to intake of some nutritional elements for kidney transplant recipients who consume Korean foods. Their main nutritional problem is obesity after transplantation. Attention should be paid to prevention of nutritional imbalance.
Calcium
;
Cardiovascular Diseases
;
Dialysis
;
Diet
;
Humans
;
Hypertension
;
Kidney Transplantation
;
Kidney*
;
Magnesium
;
Niacin
;
Obesity
;
Surveys and Questionnaires
;
Riboflavin
;
Transplantation
;
Vitamin D
7.Different Movement of Hyolaryngeal Structures by Various Application of Electrical Stimulation in Normal Individuals.
Sae Hyun KIM ; Byung Mo OH ; Tae Ryun HAN ; Ho Joong JEONG ; Young Joo SIM
Annals of Rehabilitation Medicine 2015;39(4):535-544
OBJECTIVE: To identify the differences in the movement of the hyoid bone and the vocal cord with and without electrical stimulation in normal subjects. METHODS: Two-dimensional motion analysis using a videofluoroscopic swallowing study with and without electrical stimulation was performed. Surface electrical stimulation was applied during swallowing using electrodes placed at three different locations on each subject. All subjects were analyzed three times using the following electrode placements: with one pair of electrodes on the suprahyoid muscles and a second pair on the infrahyoid muscles (SI); with placement of the electrode pairs on only the infrahyoid muscles (IO); and with the electrode pairs placed vertically on the suprahyoid and infrahyoid muscles (SIV). RESULTS: The main outcomes of this study demonstrated an initial downward displacement as well as different movements of the hyoid bone with the three electrode placements used for electrical stimulation. The initial positions of the hyoid bone with the SI and IO placements resulted in an inferior and anterior displaced position. During swallowing, the hyoid bone moved in a more superior and less anterior direction, resulting in almost the same peak position compared with no electrical stimulation. CONCLUSION: These results demonstrate that electrical stimulation caused an initial depression of the hyoid bone, which had nearly the same peak position during swallowing. Electrical stimulation during swallowing was not dependent on the position of the electrode on the neck, such as on the infrahyoid or on both the suprahyoid and infrahyoid muscles.
Deglutition
;
Deglutition Disorders
;
Depression
;
Electric Stimulation*
;
Electrodes
;
Hyoid Bone
;
Jupiter
;
Muscles
;
Neck
;
Neck Muscles
;
Vocal Cords
8.A Case of Intrathoracic Omental Herniation through the Esophageal Hiatus in a Patient with Continuous Ambulatory Peritoneal Dialysis.
Seung Ho CHOI ; Joon Seok OH ; Peel JUNG ; Han Sae KIM ; Kang Hun LEE ; Joong Kyung KIM ; Jong Hyun PARK
Korean Journal of Medicine 2014;86(6):766-769
Intrathoracic omental herniation through the esophageal hiatus is extremely rare. Here, we report a case of a 57-year-old male with continuous ambulatory peritoneal dialysis (CAPD) who was admitted to our hospital after experiencing nausea and abdominal discomfort for 3 days. Computed tomography (CT) revealed a fatty mass, extended continuously through the esophageal hiatus into the thoracic cavity. Laparoscopic surgery revealed an omental herniation through the esophageal hiatus. There was no herniation of the stomach or intestines. Peritoneal dialysis was resumed six weeks later. This is a report of omental herniation through the esophageal hiatus in a patient with CAPD.
Hernia
;
Humans
;
Intestines
;
Laparoscopy
;
Male
;
Middle Aged
;
Nausea
;
Omentum
;
Peritoneal Dialysis
;
Peritoneal Dialysis, Continuous Ambulatory*
;
Stomach
;
Thoracic Cavity
9.A Case of Immunoglobulin G4-Related Disease Presenting as a Pleural Mass.
Dong Hyun KIM ; Kyu Han KOH ; Hyeon Sik OH ; Se Joong KIM ; Sae Han KANG ; Byung Wook JUNG ; Jun Gyu SONG ; Mi Ju CHEON ; Seon Bin YOON ; Yong Won PARK ; Young Min KO ; Seung Hyeun LEE
Tuberculosis and Respiratory Diseases 2014;76(1):38-41
Immunoglobulin G4 (IgG4)-related disease is a newly recognized condition characterized by fibroinflammatory lesions with dense lymphoplasmacytic infiltration, storiform-type fibrosis and obliterative phlebitis. The pathogenesis is not fully understood but multiple immune-mediated mechanisms are believed to contribute. This rare disease can involve various organs and pleural involvement is even rarer. We report a case of IgG4-related disease involving pleura. A 66-year-old man presented with cough and sputum production for a week. Chest radiography revealed consolidation and a pleural mass at right hemithorax. Treatment with antibiotics resolved the consolidation and respiratory symptoms disappeared, but the pleural mass was unchanged. Video-assisted thoracoscopic surgery was performed. Histopathology revealed dense lymphoplasmacytic infiltration and storiform fibrosis with numerous IgG4-bearing plasma cells. The serum IgG4 level was also elevated. Further examination ruled out the involvement of any other organ. The patient was discharged without further treatment and there is no evidence of recurrence to date.
Aged
;
Anti-Bacterial Agents
;
Autoimmune Diseases
;
Cough
;
Fibrosis
;
Humans
;
Immunoglobulin G
;
Immunoglobulins*
;
Phlebitis
;
Plasma Cells
;
Pleura
;
Pleural Neoplasms
;
Radiography
;
Rare Diseases
;
Recurrence
;
Sputum
;
Thoracic Surgery, Video-Assisted
;
Thorax
10.Using Sirolimus for Posttransplant Management and Reduction of Tuberous Sclerosis Complex Progression in a Patient with End Stage Renal Disease Caused by Tuberous Sclerosis Complex.
Kang Hun LEE ; Han Sae KIM ; Sung Han YUN ; Jin Ho LEE ; Joon Seok OH ; Seung Min KIM ; Yong Hun SIN ; Joong Kyung KIM
The Journal of the Korean Society for Transplantation 2014;28(4):241-245
Tuberous sclerosis complex (TSC) is a neurocutaneous disease characterized by the formation of hamartomas in multiple organs. TSC can show lesions including facial angiofibroma, shagreen patch on the skin, cortical tuber, subependymal nodule, astrocytoma in the brain, cardiac rhabdomyoma, and renal angiomyolipoma. In particular, renal angiomyolipoma may be a cause of end-stage renal disease (ESRD). On the other hand, sirolimus has regulatory effects on cellular growth and proliferation via its inhibitory effect on a protein, mammalian target of rapamycin. We report on a case of an 18-year-old male who underwent renal transplantation due to ESRD induced by TSC. Sirolimus played a role in successful treatment of TSC and effective immunosuppression for transplantation.
Adolescent
;
Angiofibroma
;
Angiomyolipoma
;
Astrocytoma
;
Brain
;
Hamartoma
;
Hand
;
Humans
;
Immunosuppression
;
Kidney Failure, Chronic*
;
Kidney Transplantation
;
Male
;
Rhabdomyoma
;
Sirolimus*
;
Skin
;
Tuberous Sclerosis*

Result Analysis
Print
Save
E-mail